[TCTAP Workshops] Left Main and Multi-Vessel Diseases: Updated Concept and Treatment

April 25, 2024 / 2:00 PM ~ 3:50 PM 📌 Valve & Endovascular Theater, Level 2

  • May 02, 2024
  • 446
Moderator(s): Duk-Woo Park, Alan C. Yeung
Panelist(s): Ziad A. Ali, Adrian P. Banning, Scott Harding, Mamas Mamas, Yoshinobu Murasato, Bruno Scheller, Pieter Smits

  • Revascularization for Left Main Disease: Updated Data, Global Guidelines and Beyond
    Seung-Jung Park
  • OMT First With ISCHEMIA Trial: Clinical Implications and Patient Selection for Multi-Vessel PCI
    Sripal Bangalore
  • Panel Discussion I

Debate: PCI vs. Surgery
Left Main & Multi-Vessel Disease: Updates on Revascularization Strategy in 2024

  • PCI Is Enough. - When PCI Should Not Be Standard Treatment
    Duk-Woo Park
  • Surgery Is Still Better. - PCI Will Never Surpass CABG.
    David Paul Taggart
  • Panel Discussion ll

Master's Case and Review

  • Case 1. Practical Issue of Left Main & Multi-Vessel PCI: Make it Simple!
    Seung-Jung Park
  • Case 2. Choosing Wisely: FFR vs. Anatomy-guided Left Main PCI -The Rationale of the FATE-MAIN Trial
    Do-Yoon Kang
  • Case 3. Challenging Treatment in Left Main In-stent Restenosis
    Bruno Scheller
  • Case 4. Multi-Vessel PCI in Acute Coronary Syndromes
    Shamir R. Mehta
  • Panel Discussion lll
Share this Post:
Video List